rxdx acquisition：MSD Completes Acquisition of Prometheus Biosciences
MSD Completes Acquisition of Prometheus Biosciences
2023年6月16日—(“Prometheus”)(NASDAQ:RXDX)acquisition.Prometheusisnowawholly-ownedsubsidiaryofMSDandthecommonstockofPrometheuswillno ...。其他文章還包含有：「MerckAcquiresPrometheusBiosciencesfor$10.8Billion」、「MerckCompletesAcquisitionofPrometheusBiosciences」、「MerckStrengthensImmunologyPipelinewithAcquisitionof...」、「MercktobuyPrometheusBiosciencesforabout$11billion」
查看更多 離開網站
Merck Acquires Prometheus Biosciences for $10.8 Billion
https://www.investopedia.com
Shares of Prometheus Biosciences (RXDX) jumped on Monday after the maker of intestinal inflammatory disease treatments said it will be ...
Merck Completes Acquisition of Prometheus Biosciences
https://www.businesswire.com
(“Prometheus”) (NASDAQ: RXDX) acquisition. Prometheus is now a wholly-owned subsidiary of Merck and the common stock of Prometheus will no ...
Merck Strengthens Immunology Pipeline with Acquisition of ...
https://www.merck.com
(“Prometheus”) (Nasdaq: RXDX) today announced that the companies have entered into a definitive agreement under which Merck, through a ...
Merck to buy Prometheus Biosciences for about $11 billion
https://www.reuters.com
April 16 (Reuters) - Merck & Co (MRK.N) said on Sunday it will buy Prometheus Biosciences Inc (RXDX.O) for about $10.8 billion, ...